Indivior Pharmaceuticals, Inc. EPS (Earnings per Share) 2022–2025
Indivior Pharmaceuticals, Inc. reported $1.64 of earnings per share for fiscal 2025. That was 3180.0% higher than fiscal 2024. Compared with fiscal 2022, the change was +612.5%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $1.64 | +3180.0% |
| FY 2024 | $0.05 | +105.4% |
| FY 2023 | $-0.92 | -187.5% |
| FY 2022 | $-0.32 | — |
Source: Indivior Pharmaceuticals, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open INDV 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Indivior Pharmaceuticals, Inc. reported $1.64 of earnings per share for fiscal 2025. That was 3180.0% higher than fiscal 2024. Compared with fiscal 2022, the change was +612.5%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Indivior Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIndivior Pharmaceuticals, Inc. — frequently asked questions
What is Indivior Pharmaceuticals, Inc.'s earnings per share?
Indivior Pharmaceuticals, Inc. (INDV) reported earnings per share of $1.64 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Indivior Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.